Our nervous system (Brain + Spinal cord + Nerves) controls the entire body.
Every disease of the body (whether it is related to heart, lung, kidney, liver, bone or immune system) ultimately affects the nervous system through neural signaling, molecular markers or inflammation.
That is why, if we check neurobiomarkers, we can get information about the disease occurring in any part of the body.
🔹 Scientific basis
Genomic & Proteomic Level:
In every disease (cancer, diabetes, Alzheimer’s, arthritis, heart disease) some genes are active or inactive.
Neurobiomarkers capture these gene expression and protein changes.
Immune System Changes:
The immune system of the body plays a role in almost all diseases.
Neurobiomarkers indicate which cytokines, antibodies or inflammatory markers are active.
Metabolism & Energy:
In cancer cells consume more energy, in diabetes glucose metabolism is impaired, in neurodiseases there is a lack of ATP.
All these can be detected by biomarker tests.
Effect on neural networks:
When any disease becomes chronic, it causes pain, fatigue, sleep, mood or cognitive changes in the nervous system.
Neurobiomarkers show which nerve pathways are affected.
🔹 Example (Diseases & Neurobiomarker Connection)
Cardiac disease: Troponin, BNP, but also Autonomic nervous system biomarkers (HRV, catecholamines).
Cancer: Circulating tumor DNA + inflammation-based neurobiomarkers.
Diabetes: Insulin, C-peptide, and peripheral nerve injury biomarkers.
Autoimmune diseases: Autoantibodies + CNS inflammation biomarkers.
Bone and muscle diseases: Osteocalcin, CK (creatine kinase), and pain-related neurobiomarkers.
🔹 Conclusion
Neurobiomarkers are not limited to diseases of the brain or nerves.
They are useful in diseases of the whole body because every disease affects genes, cells, immune system, and nervous system.
That is why neurobiomarkers are being considered as universal tests in medicine, so that we can reach the root of the disease of the whole body with a single test.
Scientific basis in detail
1. Genomic & Proteomic Level:
The root of every disease is hidden in the cell and gene.
In cancer — genes like p53, BRCA1/2 get mutated.
In neurodisease — APOE, Tau, Amyloid precursor protein is affected.
In arthritis — HLA-B27, TNF-α pathway gets activated.
👉 Neurobiomarkers capture these subtle changes, so they can identify the disease molecularly.
—
2. Immunological changes (Immune System Changes):
The immune system is the mediator of every disease.
If there is infection with virus/bacteria → specific antibodies are formed.
If there is cancer → tumor-specific antigens are released.
If there is autoimmune disease → body attacks itself (autoantibodies like ANA, Anti-dsDNA, Anti-CCP).
👉 Neurobiomarkers reach the root cause by detecting abnormality of cytokines (IL-1β, TNF-α, IL-6) and antibodies.
—
3. Metabolism & Energy:
Every disease affects the energy system of the cell (mitochondria).
In diabetes → Insulin resistance + Glucose metabolism defect.
In cancer → Warburg effect (cells do more glycolysis).
In neurological diseases → ATP deficiency, oxidative stress.
👉 Biomarkers like lactate, pyruvate, ATP/ADP ratio indicate imbalance in metabolism.
—
4. Effect on neural network:
When the disease becomes chronic, the nervous system starts responding.
In heart disease → sympathetic overactivity (catecholamines ↑).
In diabetes → peripheral neuropathy.
In cancer → chronic pain signaling.
In autoimmune disease → demyelination, neuronal injury.
👉 Neurobiomarkers show which pathway (dopaminergic, serotonergic, GABAergic) is affected.
—
🔹 Deeper connection of examples
Heart disease:
Only increase in Troponin indicates heart cell damage,
But along with this HRV (Heart Rate Variability) and catecholamines tell us that there is also autonomic nervous system imbalance.
Cancer:
Circulating tumor DNA reveals where the cancer started,
but neuroinflammation biomarkers reveal why pain, fatigue, and cognitive decline are occurring.
Diabetes:
Insulin and C-peptide reveal the state of the pancreas,
but nerve injury biomarkers (NGF, Neurofilament light chain) reveal the level of neuropathy.
Autoimmune diseases:
Antibodies reveal the disease,
but CNS inflammation biomarkers (glial fibrillary acidic protein, S100B) reveal the extent of damage to the brain and nerves.
Bone and muscle diseases:
Osteocalcin and CK reveal the state of bone and muscle,
but pain-related biomarkers (Substance P, CGRP) reveal the source of pain.
—
🔹 Strengthening the Conclusion
Neurobiomarker testing is multi-dimensional — it shows the interrelationship between the entire body + nervous system, not just one disease.
Every disease ultimately affects neural signaling + immune system + metabolism + genes.
That is why neurobiomarkers can be called a universal diagnostic tool.
In the future, doctors will be able to get a complete map of the patient’s brain, heart, bones, metabolism and immune system with a single neurobiomarker panel test.